European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Novo Nordisk A/S, Bagsværd, Denmark

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Novo Nordisk A/S
Novo Industri A/S
Nordisk Gentofte A/S
Nordisk Insulinlaboratorium A/S
Novo Terapeutisk Laboratorium A/S

Identification

Cvrcom
CVR 24256790
Ccrcom
The Brønnøysund Register Centre 936343414
Stockp
NONOF NOV.DE NOVC.DE NVO
Lei
549300DAQ1CVT6CXN342
EUID
DKCVR.24256790

Address

Novo Alle, 2880 Bagsværd, Denmark

Corporate purpose

21.20.00
Manufacture of pharmaceutical preparations

The purpose of the company is to research, develop, produce and market pharmaceutical, medical and technical products and services as well as other related activities as determined by the Board of Directors. The company strives to conduct its business in an economically, environmentally and socially responsible manner.

Financial performance

History

Persons

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives (22) · Current shareholders (2) · Active participations (6)
This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Financials

Key Performance Indicators: Financial (5) · Mktg & Tech (5)

The following indicators are on file for this company: Base/share capital · Total assets · Earnings · Earnings CAGR · Revenue · Revenue CAGR · Return on sales · Equity · Equity ratio · Return on equity · Taxes · Tax ratio · Cash on hand · Receivables · Liabilities · Patents · Trademarks · Number of public fundings

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Annual report  

Publications

Year 2026 in Epobase
5 European patent filings: Fixed Dose Injection Device …
7 Apr 2026
Member of the board: Helena Ildiko Saxon · Company statute
Year 2026 in Euipotm
26 trademark filings (21 wordmarks, 5 figurative marks): Axessovo, Ayonzilo, Coureli, Kayshild, Kyinsu, Life, made lighter, Live Lighter, NovoCare, Ocempec, Ocempic, Ocimpec, Omrifio, Osempec …
27 Mar 2026
Annual report for the year ending 31/12/2025
26 Mar 2026
Deputy member of the board: Hassan Kassem
26 Mar 2026
Member of the board: Désireé J. Asgreen
26 Mar 2026
No longer Member of the board: L. Hyveled-Nielsen
26 Mar 2026
No longer Deputy member of the board: Anders Kaae
26 Mar 2026
Deputy member of the board: Tanja Villumsen
26 Mar 2026
No longer Deputy member of the board: Jesper Thorning
26 Mar 2026
No longer Deputy member of the board: Karina Bonde Lenau
26 Mar 2026
Deputy member of the board: Tamara Schmidt
26 Mar 2026
Member of the board: Helena Ildiko Saxon
26 Mar 2026
Member of the board: Ramona A. Sequeira
26 Mar 2026
Member of the board: J. van de Winkel
26 Mar 2026
Member of the board: Semsi Kilic Madsen
26 Mar 2026
Deputy member of the board: Trine H. Kristiansen
25 Mar 2026
No longer Member of the board: Tanja Villumsen
14 Mar 2026
European Union Transparency Register
4 Feb 2026
Dismissed: Thomas Rantzau
4 Feb 2026 as NOVO NORDISK A/S
U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system
31 Jan 2026
No longer Member of the board: Thomas Rantzau
31 Jan 2026
Member of the board: Tanja Villumsen
30 Jan 2026
No longer Deputy member of the board: Tanja Villumsen
1 Jan 2026 via A. Menarini Farmaceutica Internazionale Srl
EU funding: Cities@Heart: City-based Strategies for improving Cardiovascular Health in Europe
31 Dec 2025
Balance sheet for 31/12/2025 · Earnings statement for 31/12/2025
Year 2025 in Epobase
28 European patent filings: A Torsion Spring Driven Injection Device …
Year 2025 in Euipotm
33 wordmarks: AM Biologics Filling, APOLLO by Novo Nordisk, Anuetake, Awoncy, Besqw, BioFill Aseptic Manufacturing, Civovic, Coureli, Extensior, Glemway, Greduzy, Live Lighter, NovoCare, NovoWeCare …
Year 2025 in Hor
7 EU fundings (€0.00): Patient Relevant Osteoarthritis endpoints using Big data Evaluation …
14 Nov 2025
Member of the board: Stephan Engels · No longer Member of the board: Helge Lund
14 Nov 2025
Member of the board: Britt Meelby Jensen
14 Nov 2025
Chair of the board: Lars Rebien Sørensen
14 Nov 2025
No longer Vice chair of the board: Henrik Poulsen
14 Nov 2025
No longer Member of the board: S. Louise Grégoire
14 Nov 2025
No longer Chair of the board: Helge Lund
14 Nov 2025
No longer Member of the board: Andreas Helmut Fibig
14 Nov 2025
No longer Member of the board: Martin W. Mackay
14 Nov 2025
No longer Member of the board: Laurence Debroux
14 Nov 2025
Vice chair of the board: Cornelis de Jong
14 Nov 2025
Member of the board: Stephan Engels
14 Nov 2025
No longer Member of the board: Choi L. Ch. Law
5 Nov 2025
Annual report for the year ending 30/09/2025
7 Aug 2025
Director: Maziar Doustdar · No longer Director: Lars F. Jørgensen
7 Aug 2025
Director: Maziar Doustdar
6 Aug 2025
Annual report for the year ending 30/06/2025
6 Aug 2025
No longer Director: Lars F. Jørgensen
7 May 2025
Annual report for the year ending 31/03/2025
28 Mar 2025
Annual report for the year ending 31/12/2024
28 Mar 2025
Company statute
5 Feb 2025 as NOVO NORDISK A/S
U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system
31 Dec 2024
Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024
Year 2024 in Epobase
63 European patent filings: System Providing Dose Recommendations for Basal Insulin Titration …
Year 2024 in Hor
9 EU fundings (€0.00): Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments …
16 Dec 2024 in Sat
State Aid (1,642,570 DKK): Subsidies for energy savings, energy efficiency improvements and CO2 reductions in businesses (Business Pool)
via CVR in Cvrpc
Shareholdings: Creek Denmark HoldCo ApS, Nnit A/S, Nnit A/S · No longer Voting rights: Creek Denmark HoldCo ApS, Nnit A/S, Nnit A/S · Shareholdings (4 companies) · Voting rights (4 companies)
Year 2024 in Euipotm
67 trademark filings (61 wordmarks, 4 figurative marks, 2 word figurative marks): Amvelous, Blyom, CLEAN, ClearDose, DiaScope, Evoleed, Evophia, Fiatruze, GeDiForCE, Gladitude, Ivokery, Konimba …
6 Nov 2024
Annual report for the year ending 30/09/2024
24 Sept 2024 via GANÉ Investment-AG mit Teilgesellschaftsvermögen
Shareholder: GANÉ Investment-AG mit Teilgesellschaftsvermögen
16 Sept 2024
Patent: Feste Zusammensetzungen zur Oralen Verabreichung
7 Aug 2024
Annual report for the year ending 30/06/2024
8 Jul 2024 via First Private Investment Management KAG mbH also 29/04/2024
Shareholder: First Private Investment Management KAG mbH
13 Jun 2024 in Sat
State Aid (1,242,000 DKK): Industrial Postdoc
2 May 2024
Annual report for the year ending 31/03/2024
24 Apr 2024
Capital: 446.5M DKK · Company statute
3 Apr 2024
Annual report for the year ending 31/12/2023
21 Mar 2024
Auditor: Deloitte Statsautoriseret P/S
21 Mar 2024
Capital: 4,500,000 DKK · Company statute
31 Jan 2024 as NOVO NORDISK A/S
U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system
5 Jan 2024
No longer Director: Martin Holst Lange
31 Dec 2023
No longer Director: Henrik Ehlers Wulff
31 Dec 2023
No longer Director: Camilla Sylvest
31 Dec 2023
No longer Director: Marcus Schindler
31 Dec 2023
No longer Director: Martin Holst Lange
31 Dec 2023
Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
Year 2023 in Sat
6 State Aids (total €1,810,824): Energy and CO2 tax reliefs …
Year 2023 in Epobase
56 European patent filings: Site Directed Mutagenesis of Trem-1 Antibodies for Decreasing Viscosity. …
Year 2023 in Hor
6 EU fundings (€0.00): GRIP on MASH: Global Research Initiative for Patient Screening on MASH …
Year 2023 in Euipotm
44 trademark filings (33 wordmarks, 11 figurative marks): Altastiq, Annocta, Diabetes Care Excellence Model, Diabetes Quality Model, DisoNNex, DuraTouch, Emimful, Emybook, Eptacty, Esnesq, HaemoNet …
2 Nov 2023
Annual report for the year ending 30/09/2023
10 Aug 2023
Annual report for the year ending 30/06/2023
4 May 2023
Annual report for the year ending 31/03/2023
26 Apr 2023
Capital: 451M DKK · Company statute
27 Mar 2023
Annual report for the year ending 31/12/2022
23 Mar 2023
No longer Member of the board: Jeppe Christiansen · Capital: 5,000,000 DKK · Company statute
23 Mar 2023
No longer Member of the board: Jeppe Christiansen
7 Mar 2023
No longer Director: Monique P. Carter
7 Mar 2023
No longer Director: Monique P. Carter
1 Feb 2023 as NOVO NORDISK A/S
U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system
31 Dec 2022
Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
31 Dec 2022 in Sat
State Aid (214.7M DKK): Amendment of the law on the taxation of electricity (reduction of electricity tax on rides)
31 Dec 2022 in Sat
State Aid (5,743,092 DKK): Energy and CO2 tax reliefs
Year 2022 in Euipotm
68 trademark filings (67 wordmarks, 1 word figurative mark): Adjaris, Amplioza, Aweeqli, Awiqli, Bemrelfy, DIALOG, DUAL, Don't weight for diabetes, Duvicta, Duzodan, Duzodec, Extensior, Fianzadec …
Year 2022 in Epobase
71 European patent filings: Process for the Backbone Deprotection of Oligonucleotides Containing a Terminal Alkyl Phosphonate Group …
28 Nov 2022 via Breakthrough T1D Non profit corporation
EU funding (€150,000): Real-world evidence for decisions in diabetes
25 Nov 2022 via Cambridge Innovation Technologies Consulting Ltd.
EU funding (€430,688): Development of a multifunctional biomaterial patch for buccal delivery of peptide-analogue treatments
3 Nov 2022
Annual report for the year ending 30/09/2022
4 Aug 2022
Annual report for the year ending 30/06/2022
Year 2022 in Euipods
4 registered designs
1 Jun 2022 via Agilent Technologies LDA UK Ltd.
EU funding (€424,250): Next generation toolbox for greener pharmaceuticals design & manufacturing towards reduced environmental impact
29 Apr 2022
Annual report for the year ending 31/03/2022
27 Apr 2022
Capital: 456M DKK · Company statute
28 Mar 2022
Member of the board: Jeppe Christiansen · Dismissed: Anne Kverneland · Capital: 6,000,000 DKK · Company statute
25 Mar 2022
Annual report for the year ending 31/12/2021
24 Mar 2022
No longer Member of the board: Stig Strøbæk
24 Mar 2022
No longer Member of the board: Anne Kverneland
24 Mar 2022
Vice chair of the board: Henrik Poulsen
24 Mar 2022
Member of the board: Jeppe Christiansen
24 Mar 2022
Member of the board: L. Hyveled-Nielsen
24 Mar 2022
Member of the board: Choi L. Ch. Law
24 Mar 2022
Member of the board: E. D. Christensen
23 Mar 2022
No longer Member of the board: Henrik Poulsen
23 Mar 2022
No longer Vice chair of the board: Jeppe Christiansen
2 Feb 2022 as NOVO NORDISK A/S
U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system
31 Dec 2021
Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
31 Dec 2021 in Sat
State Aid (204.8M DKK): Amendment of the law on the taxation of electricity (reduction of electricity tax on rides)
31 Dec 2021 in Sat
State Aid (3,065,225 DKK): Energy and CO2 tax reliefs
Year 2021 in Epobase
108 European patent filings: CO-Agonists of the GLP-1 and Amylin Receptors …
Year 2021 in Euipotm
49 trademark filings (46 wordmarks, 3 word figurative marks): Alsynct, Basopran, Dinsulom, Dosiba Intellidose, Dovervo, Duampic, Dursulis, Evidence, FlexPad, Full STEP, GAPP, Insulatard NPH, Kezulta …
5 Nov 2021
Annual report for the year ending 30/09/2021
28 Oct 2021
Patent: Aktivierbare Arzneimittelabgabevorrichtung mit Sicherheitsbaugruppe
21 Oct 2021
Registered Design: Injection devices
21 Oct 2021
Registered Design: Injection devices
1 Oct 2021 in Hor
EU funding: Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies
1 Sept 2021 in Hor
EU funding: BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe
12 Aug 2021
Annual report for the year ending 30/06/2021
12 May 2021
Annual report for the year ending 31/03/2021
10 May 2021
Wordmark: “Novo Akademie“
27 Apr 2021
Capital: 462M DKK · Company statute
26 Mar 2021
Annual report for the year ending 31/12/2020
25 Mar 2021
Board: Henrik Poulsen · No longer Board: Brian F. Daniels · Auditor: Deloitte Statsautoriseret P/S · No longer Auditor: Pricewaterhousecoopers Statsautoriseret P/S · Capital: 8,000,000 DKK …
25 Mar 2021
Member of the board: Henrik Poulsen
25 Mar 2021
No longer Member of the board: Elizabeth A. Hewitt
25 Mar 2021
No longer Member of the board: Brian F. Daniels
25 Mar 2021
No longer Auditor: Pricewaterhousecoopers Statsautoriseret P/S
25 Mar 2021
Auditor: Deloitte Statsautoriseret P/S
1 Mar 2021
Director: Martin Holst Lange · No longer Director: Mads K. Thomsen
1 Mar 2021
Director: Marcus Schindler
1 Mar 2021
Director: Martin Holst Lange
28 Feb 2021
No longer Director: Mads K. Thomsen
19 Feb 2021
Registered Design: Injection devices
3 Feb 2021 as NOVO NORDISK A/S
U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system
31 Dec 2020
Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
31 Dec 2020 in Sat
State Aid (181.5M DKK): Amendment of the law on the taxation of electricity (reduction of electricity tax on rides)
31 Dec 2020 in Sat
State Aid (1,249,466 DKK): Energy and CO2 tax reliefs
Year 2020 in Epobase
125 European patent filings: Adaptive System for Optimizing a Drug Dosage Regimen Over Time …
Year 2020 in Hor
8 EU fundings (€897,522): Central Repository for Digital Pathology …
Year 2020 in Euipotm
100 trademark filings (98 wordmarks, 1 figurative mark, 1 word figurative mark): Agluvan, Alicto, BEGIN, BOOST, DIALOQ, Deginex, Degizen, Degizon, Deglea, Deglecta, Deglera, Degluvant, Delonec …
13 Nov 2020
Annual report for the year ending 30/09/2020
12 Nov 2020
Company statute
Year 2020 in Euipods
9 registered designs
19 Aug 2020
Annual report for the year ending 30/06/2020
3 Jul 2020
Patent: Injektionsvorrichtung mit einer Ausstossinformationaufnehmenden Rechnereinheit
14 May 2020
Annual report for the year ending 31/03/2020
28 Apr 2020
Capital: 470M DKK · Company statute
8 Apr 2020
Annual report for the year ending 31/12/2019
26 Mar 2020
Capital: 10M DKK · Company statute
5 Feb 2020 as NOVO NORDISK A/S
U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system
31 Dec 2019
Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
31 Dec 2019 in Sat
State Aid (176.6M DKK): Amendment of the law on the taxation of electricity (reduction of electricity tax on rides)
31 Dec 2019 in Sat
State Aid (19.7M DKK): Energy and CO2 tax reliefs
26 Dec 2019
Patent: Arzneimittelabgabevorrichtung mit Dosierungserfassungsmodul
Year 2019 in Epobase
88 European patent filings: Compositions and Methods for Inhibiting HMGB1 Expression …
19 Nov 2019
Annual report for the year ending 30/09/2019
Year 2019 in Euipotm
17 trademark filings (15 wordmarks, 2 other marks): AutoFlex, Changing Obesity, Conquer, Diabetes Quality Circle, ELIOT, FlexFriend, FlexGo, FlexLife, FlexPal, NovoLet, ReadiGo, SOLVE, Time to Eat …
Year 2019 in Hor
5 EU fundings (€0.00): EU Patient- cEntric clinicAl tRial pLatform …
1 Nov 2019
Registered Design: Containers for medical purposes
4 Sept 2019
Annual report for the year ending 30/06/2019
2 Sept 2019
No longer Director: Lars Green
31 Aug 2019
No longer Director: Lars Green
12 Aug 2019
Director: Monique P. Carter
9 Aug 2019
Director: Monique P. Carter
27 May 2019
Annual report for the year ending 31/03/2019
24 Apr 2019
Capital: 480M DKK · Company statute
16 Apr 2019
No longer Director: Jesper Brandgaard
15 Apr 2019
No longer Director: Jesper Brandgaard
9 Apr 2019
Annual report for the year ending 31/12/2018
21 Mar 2019
Member of the board: Laurence Debroux · Capital: 10M DKK · Company statute
21 Mar 2019
Member of the board: Laurence Debroux
1 Mar 2019
Patent: Interne Nadeleinführvorrichtung
4 Feb 2019 as NOVO NORDISK A/S
U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system
2 Jan 2019 as Novo-Nordisk A/S
Patent: Medizinische Injektionsvorrichtung
31 Dec 2018
Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
31 Dec 2018 in Sat
State Aid (33.2M DKK): Elpatronordningen
31 Dec 2018 in Sat
State Aid (193.5M DKK): The Danish Electricity Tax Reimbursement Scheme
Year 2018 in Epobase
91 European patent filings: Compositions Comprising a Delivery Agent and Preparation Thereof …
Year 2018 in Dpmam
4 trademark filings: HERMEDICO, NovoSmart, NovoTwist, PROTAPHANE
Year 2018 in Euipotm
12 wordmarks: ACTULIN, DIALOQ, Gleptix, HbA1CV, NovoSmart, Ozempion, Pozemtive, Rybelsus, Rybeltis, UNVEIL, Zembrilio, Zymbrant
8 Nov 2018
Annual report for the year ending 30/09/2018
1 Sept 2018 in Hor
EU funding: Ensuring the future of EUPATI beyond 2020
24 Aug 2018
Annual report for the year ending 30/06/2018
Year 2018 in Dpmap
10 patent filings: Nadelkanüle, Injektionsnadelanordnung für eine Injektionsvorrichtung und Injektionsvorrichtung mit Solch einer Anordnung …
19 Jun 2018
Annual report for the year ending 31/03/2018
1 May 2018 in Hor
EU funding: Hypoglycaemia - REdefining SOLutions for better liVEs
24 Apr 2018
Capital: 490M DKK · Company statute
29 Mar 2018
Annual report for the year ending 31/12/2017
23 Mar 2018
Persons
22 Mar 2018
Member of the board: Helge Lund · Capital: 10M DKK
22 Mar 2018
No longer Member of the board: Søren Th. Pedersen
22 Mar 2018
No longer Deputy member of the board: Michael Munksø
22 Mar 2018
No longer Deputy member of the board: Désireé J. Asgreen
22 Mar 2018
No longer Member of the board: L. Hyveled-Nielsen
22 Mar 2018
Deputy member of the board: Anders Kaae
22 Mar 2018
Member of the board: Mette Bøjer Jensen
22 Mar 2018
No longer Chair of the board: Göran Ando
22 Mar 2018
Chair of the board: Helge Lund
22 Mar 2018
Member of the board: Andreas Helmut Fibig
22 Mar 2018
Member of the board: Martin W. Mackay
22 Mar 2018
Member of the board: Thomas Rantzau
22 Mar 2018
Deputy member of the board: Tanja Villumsen
22 Mar 2018
Deputy member of the board: Jesper Thorning
22 Mar 2018
Deputy member of the board: Karina Bonde Lenau
21 Mar 2018
No longer Deputy member of the board: Anders Kaae
21 Mar 2018
No longer Deputy member of the board: Mette Bøjer Jensen
21 Mar 2018
No longer Member of the board: Helge Lund
1 Mar 2018 in Hor
EU funding: Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.
15 Feb 2018
Director: Karsten Munk Knudsen
15 Feb 2018
Director: Karsten Munk Knudsen
8 Feb 2018 as NOVO NORDISK A/S
U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system
31 Dec 2017
Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
Year 2017 in Epobase
71 European patent filings: Pramlintide Derivatives …
7 Nov 2017
Annual report for the year ending 30/09/2017
Year 2017 in Dpmap
59 patent filings: Medikamentenabgabesystem mit Dosiserfassung …
Year 2017 in Hor
4 EU fundings (€290,082): Liver Investigation: Testing Marker Utility in Steatohepatitis …
Year 2017 in Euipotm
7 trademark filings (4 wordmarks, 1 figurative mark, 2 word figurative marks): ACTION - Achieving Control Through Insulin plus Oral ageNts, DoseMan, NovoLife, Redefiniendo la Obesidad …
2 Oct 2017
Director: Camilla Sylvest
1 Oct 2017
Director: Camilla Sylvest
1 Oct 2017
Director: Camilla Sylvest
Year 2017 in Dpmam
4 trademark filings: Clair, Freelin, ULTRAPHANE, ULTRATARD
16 Aug 2017
Annual report for the year ending 30/06/2017
3 Jul 2017
Director: Lars Green
1 Jul 2017
Director: Lars Green
17 May 2017
No longer Member of the board: Mary Teresa Szela
16 May 2017
No longer Member of the board: Mary Teresa Szela
11 May 2017
Annual report for the year ending 31/03/2017
21 Apr 2017
Capital: 500M DKK · Company statute
30 Mar 2017
Annual report for the year ending 31/12/2016
23 Mar 2017
Member of the board: Kasim Kutay · No longer Member of the board: Bruno F. J. Angelici · Capital: 10M DKK
23 Mar 2017
No longer Member of the board: Bruno F. J. Angelici
23 Mar 2017
Member of the board: Kasim Kutay
23 Mar 2017
Member of the board: Helge Lund
2 Jan 2017
Director: Lars F. Jørgensen
1 Jan 2017
Director: Lars F. Jørgensen
31 Dec 2016
No longer Director: Lars Rebien Sørensen
31 Dec 2016
No longer Director: Lars F. Jørgensen
31 Dec 2016
Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
31 Dec 2016 in Sat
State Aid (92.1M DKK): The Danish Electricity Tax Reimbursement Scheme
Year 2016 in Dpmam
27 trademark filings: Captain NovoCare, Clair, EpiCare, Freelin, HERMEDICO, HIGHLIGHTS NovoCare, INTERNATIONAL DIABETES MONITOR - NovoCare, MIXTARD, NORDITROPIN, NOVOJECT, NovoPen 3 Demi, NovoSmart …
Year 2016 in Epobase
68 European patent filings: Mechanism for Sequential Dose Delivery …
Year 2016 in Dpmap
98 patent filings: Gehäuse für eine Medizinische Injektionsvorrichtung …
Year 2016 in Euipotm
13 trademark filings (11 wordmarks, 2 word figurative marks): DAWN Diabetes Attitudes Wishes and Needs, Fasonsia, Great times follow mealtimes, LE CERCLE DU DEUXIÈME TYPE, Nov'Educ, NovoMet, Racing …
7 Nov 2016
Annual report for the year ending 30/09/2016
6 Sept 2016
Annual report for the year ending 30/06/2016
1 Sept 2016
Director: Henrik Ehlers Wulff · No longer Director: Jakob Riis
1 Sept 2016
Director: Henrik Ehlers Wulff
1 Sept 2016
No longer Director: Jakob Riis
1 Sept 2016 in Hor
EU funding: Biomarker Enterprise to Attack DKD - Sofia ref.: 115974
1 Sept 2016 in Hor
EU funding (€580,164): Unraveling Principles of PDZ-mediated Cell Signaling
26 May 2016
Annual report for the year ending 31/03/2016
18 Apr 2016
Capital: 510M DKK · Company statute
1 Apr 2016 in Hor
EU funding: Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881
31 Mar 2016
Annual report for the year ending 31/12/2015
18 Mar 2016
Member of the board: Brian F. Daniels · No longer Member of the board (1) · Capital: 10M DKK · Company statute
18 Mar 2016
No longer Member of the board (1)
18 Mar 2016
No longer Member of the board (1)
18 Mar 2016
Member of the board: Brian F. Daniels
31 Dec 2015
Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
Year 2015 in Dpmap
101 patent filings: Stiftförmige Injektionsvorrichtung mit Torsionsfederantrieb …
Year 2015 in Epobase
85 European patent filings: Process for Shaping a Needle Cannula …
Year 2015 in Euipotm
23 wordmarks: Allizeq, Awoncy, Besqw, Brenlion, Brensana, Civovic, Greduzy, Ocempec, Ocempic, Ocimpec, Oprevio, Osempec, Osempic, Osimpec, Ozempec …
4 Nov 2015
Annual report for the year ending 30/09/2015
1 Nov 2015 in Hor
EU funding: Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797
Year 2015 in Dpmam
4 trademark filings: GABITRIL, HERMEDICO, NovoStrip, PROTAPHANE
18 Aug 2015
Annual report for the year ending 30/06/2015
1 Jul 2015 in Hor
EU funding: Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890
17 May 2015
Annual report for the year ending 31/03/2015
30 Apr 2015
No longer Director (1)
30 Apr 2015
No longer Director (1)
22 Apr 2015
Capital: 520M DKK
31 Mar 2015
Annual report for the year ending 31/12/2014
19 Mar 2015
Member of the board (1) · No longer Member of the board (1) · Capital: 10M DKK · Company statute
19 Mar 2015
Member of the board (1)
19 Mar 2015
No longer Member of the board (1)
19 Mar 2015
No longer Member of the board: Helge Lund
19 Mar 2015
Member of the board: S. Louise Grégoire
19 Mar 2015
Member of the board: Mary Teresa Szela
1 Jan 2015 via Ecole Polytechnique Federale de Lausanne
EU funding (€290,082): Multi-Stimuli Responsive Molecular Systems and Materials
31 Dec 2014
Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
Year 2014 in Epobase
54 European patent filings: Medical Injection Device with Time Delay Indicator …
Year 2014 in Dpmap
107 patent filings: GLP-1-Derivate und Verwendungen Davon …
25 Nov 2014
No longer Director (1)
24 Nov 2014
No longer Director (1)
5 Nov 2014
Annual report for the year ending 30/09/2014
2 Sept 2014
Annual report for the year ending 30/06/2014
Year 2014 in Euipotm
10 wordmarks: COEXA, Capavar, Careway, FIAsp, Gatelsa, Inspira, Liprega, Procover, Saxenda, VIVENTIL
23 Jul 2014
Annual report for the year ending 31/03/2014
Year 2014 in Dpmam
4 trademark filings: NOVOPEN, NordiPaq, PENFILL, Trisequens
11 May 2014 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
23 Apr 2014
Capital: 530M DKK · Company statute
1 Apr 2014
Annual report for the year ending 31/12/2013
21 Mar 2014
Member of the board: L. Hyveled-Nielsen · No longer Member of the board (1)
20 Mar 2014
Member of the board: Helge Lund · No longer Member of the board (1) · Capital: 20M DKK · Company statute
20 Mar 2014
No longer Member of the board (1)
20 Mar 2014
No longer Deputy member of the board (1)
20 Mar 2014
No longer Deputy member of the board (1)
20 Mar 2014
No longer Deputy member of the board (1)
20 Mar 2014
Deputy member of the board: Michael Munksø
20 Mar 2014
No longer Member of the board (1)
20 Mar 2014
No longer Deputy member of the board (1)
20 Mar 2014
Deputy member of the board: Désireé J. Asgreen
20 Mar 2014
Member of the board: L. Hyveled-Nielsen
20 Mar 2014
Deputy member of the board: Anders Kaae
20 Mar 2014
Deputy member of the board: Mette Bøjer Jensen
20 Mar 2014
Member of the board: Helge Lund
18 Mar 2014 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
31 Dec 2013
Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
Year 2013 in Epobase
63 European patent filings: High Temperature Dead END Antibody Filtration …
Year 2013 in Dpmap
131 patent filings: Glucagonanaloga mit GIP-Rezeptoraktivität …
Year 2013 in Dpmam
54 trademark filings: ACTRAPHAN, ACTRAPHANE, Ariantro, Brenlion, Brensana, Capavar, Captain NovoCare, Clair, EpiCare, Freelin, GABITRIL, Galfazar, Gatelsa, HERMEDICO, HIGHLIGHTS NovoCare …
5 Nov 2013
Annual report for the year ending 30/09/2013
Year 2013 in Euipotm
11 trademark filings (10 wordmarks, 1 word figurative mark): Ariantro, Durafix, FEF, Liaglex, Lirasmart, Prydectia, Prydentra, Unigluc, Vivexis, Xultophy …
9 Sept 2013
Annual report for the year ending 30/06/2013
7 Aug 2013 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
7 Aug 2013 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
16 Jul 2013 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
17 May 2013
Annual report for the year ending 31/03/2013
22 Apr 2013
Capital: 550M DKK · Company statute
4 Apr 2013
Annual report for the year ending 31/12/2012
20 Mar 2013
Director: Jeppe Christiansen · Member of the board: Jeppe Christiansen · No longer Member of the board (1) · Capital: 10M DKK · Company statute
20 Mar 2013
No longer Member of the board (1)
20 Mar 2013
No longer Chair of the board (1)
20 Mar 2013
Vice chair of the board: Jeppe Christiansen
20 Mar 2013
Chair of the board: Göran Ando
31 Jan 2013
Director: Lars F. Jørgensen
31 Jan 2013
Director: Lars F. Jørgensen
31 Jan 2013
Director: Jakob Riis
31 Dec 2012
Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
Year 2012 in Epobase
60 European patent filings: N-Terminally Modified Insulin Derivatives …
Year 2012 in Dpmap
67 patent filings: Selektive Eliminierung Erosiver Zellen …
Year 2012 in Euipotm
11 wordmarks: ASPITEC, AVIAXX, Evidence, FERTAQ, LINDIAL, MEIOTIQ, NovoBasix, NovoLinea, Ryzodeg, THE POWER OF², Weladeg
Year 2012 in Dpmam
12 trademark filings: ACTRAPID, GESTRIFAM, KLIOGEST, MIXTARD, MONOSULIN, NordiTest, NovoCheck, NovoNorm, RAPITARD, VELASULIN …
14 Nov 2012
Annual report for the year ending 30/09/2012
24 Aug 2012
Annual report for the year ending 30/06/2011
24 Aug 2012
Annual report for the year ending 30/06/2012
23 Aug 2012 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
14 May 2012
Annual report for the year ending 31/03/2012
23 Apr 2012
Capital: 560M DKK · Company statute
18 Apr 2012
Annual report for the year ending 31/12/2011
21 Mar 2012
Member of the board: Elizabeth A. Hewitt · No longer Member of the board (1) · Capital: 20M DKK · Company statute
21 Mar 2012
No longer Member of the board (1)
21 Mar 2012
Member of the board: Elizabeth A. Hewitt
31 Dec 2011
Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
Year 2011 in Dpmap
44 patent filings: Medizinischer Behälter mit Schutz vor Rissbildung …
Year 2011 in Epobase
77 European patent filings: Medical Injection Device …
Year 2011 in Euipotm
5 trademark filings (4 wordmarks, 1 figurative mark): Diabetes Barometer, Gabitril, INDUO, NAVIGO …
Year 2011 in Dpmam
21 trademark filings: ASPILINX, ASPITEC, AVIAXX, Cellusile, CheckPoint, DiabetesLife, FERTAQ, FERTUNE, GlucaGen, INDUO, LINDIAL, MEIOTAQ, MEIOTEC, MEIOTEQ, MEIOTIQ …
7 Nov 2011
Annual report for the year ending 30/09/2011
1 Oct 2011
Auditor: Pricewaterhousecoopers Statsautoriseret P/S · No longer Auditor: Pricewaterhousecoopers Services Statsautoriseret A/S
4 Sept 2011 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
21 Aug 2011 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
1 Jul 2011
Auditor: Pricewaterhousecoopers Statsautoriseret P/S
1 Jul 2011
No longer Auditor: Pricewaterhousecoopers Services Statsautoriseret A/S
17 Jun 2011 via Novo Nordisk North America Operations A/S
Founder: Novo Nordisk North America Operations A/S
4 May 2011
Annual report for the year ending 31/03/2011
2 May 2011
Capital: 580M DKK · Company statute
5 Apr 2011
Annual report for the year ending 31/12/2010
31 Mar 2011 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
31 Mar 2011 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
28 Mar 2011
Member of the board (1)
25 Mar 2011
Member of the board: Bruno F. J. Angelici · No longer Member of the board (1) · Capital: 20M DKK · Company statute
23 Mar 2011
No longer Member of the board (1)
23 Mar 2011
Member of the board (1)
23 Mar 2011
Member of the board: Bruno F. J. Angelici
31 Dec 2010
Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
Year 2010 in Dpmap
81 patent filings: Präparat, das Insulin, Nikotinamid und Arginin Umfasst …
Year 2010 in Epobase
43 European patent filings: Medical Delivery System with Asymmetrical Coding Means …
Year 2010 in Dpmam
11 trademark filings: BIOTREAT, INSULATARD, NOVOLET, Niatrim, Novo-Nordisk, NovoLet, Novodyn, Novoestell, UNILIN …
Year 2010 in Euipotm
30 trademark filings (25 wordmarks, 3 figurative marks, 1 word figurative mark, 1 other mark): Actrapid, Altruso, Bivonia, Cereez, Degloza, EasyFlex, Echo, Efitrek, FlexCeed, Get to the root of …
2 Nov 2010
Annual report for the year ending 30/09/2010
27 Oct 2010
Annual report for the year ending 30/06/2010
4 Aug 2010 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
28 Jun 2010
Capital: 600M DKK · Company statute
3 May 2010
Annual report for the year ending 31/03/2010
6 Apr 2010
Annual report for the year ending 31/12/2009
25 Mar 2010
Member of the board (1) · No longer Member of the board (1) · Capital: 20M DKK · Company statute
24 Mar 2010
No longer Member of the board (1)
24 Mar 2010
Deputy member of the board (1)
24 Mar 2010
Deputy member of the board (1)
24 Mar 2010
Member of the board (1) · No longer Deputy member of the board (1)
24 Mar 2010
No longer Deputy member of the board (1)
31 Dec 2009
Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009
Year 2009 in Euipotm
10 trademark filings (9 wordmarks, 1 figurative mark): Centeniase, EziFlex, FlexPen, FlexTouch, Grab Diabetes by the Roots, NovoCap, NovoFine, NovoPen Echo, NovoTwist …
Year 2009 in Dpmap
47 patent filings: Nadel …
Year 2009 in Epobase
55 European patent filings: Dose Setting Limiting Device …
Year 2009 in Dpmam
97 trademark filings: ACTRAPHAN, ACTRAPHANE, ACTRAPID, ASPILINX, ASPITEC, AVIAXX, Ariantro, BIOTREAT, Brenlion, Brensana, Capavar, Captain NovoCare, Cellusile, CheckPoint, Clair …
19 Nov 2009
Annual report for the year ending 30/09/2009
10 Nov 2009 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
27 Oct 2009 via Innate Pharma SA
Member of the Supervisory Board: Innate Pharma SA
24 Aug 2009
Annual report for the year ending 30/06/2009
22 Jun 2009
Capital: 620M DKK · Company statute
4 May 2009
Annual report for the year ending 31/03/2009
20 Mar 2009
Annual report for the year ending 31/12/2008
19 Mar 2009
Member of the board (1) · No longer Member of the board (1) · Capital: 14M DKK · Company statute
18 Mar 2009
No longer Member of the board (1)
18 Mar 2009
Member of the board (1)
31 Dec 2008
Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
Year 2008 in Epobase
82 European patent filings: Injection Device …
Year 2008 in Dpmap
28 patent filings: Pharmazeutische Formulierung Enthaltend ein Insulinderivat …
Year 2008 in Dpmam
11 trademark filings: Clair, FENOXYPEN, HYPOGON, INSUJECT, MENOQUENS, NORDITROPIN, Noviana, NovoClone, PENMIX …
Year 2008 in Euipotm
5 trademark filings (4 wordmarks, 1 word figurative mark): NordiReg, NovoLog, NovoRapid, NovoTrain …
20 Nov 2008 via Novo Nordisk Invest 4 A/S
Founder: Steno Diabetes Center A/S
5 Nov 2008
Annual report for the year ending 30/09/2008
22 Aug 2008
Annual report for the year ending 30/06/2008
13 Jun 2008
Capital: 634M DKK · Company statute
5 May 2008
Annual report for the year ending 31/03/2008
1 Apr 2008
Company statute
26 Mar 2008
Member of the board: Pamela J. Kirby · No longer Member of the board (1)
18 Mar 2008
Annual report for the year ending 31/12/2007
12 Mar 2008
No longer Member of the board (1)
12 Mar 2008
Member of the board (1)
12 Mar 2008
Capital: 13M DKK
31 Dec 2007
Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
Year 2007 in Epobase
92 European patent filings: Stable Formulation of Modified GLP-1 …
Year 2007 in Euipotm
5 wordmarks: ADAPT, Autocover, Glutenase, INNOVO, NSERT
Year 2007 in Dpmap
22 patent filings: Erweiterte GLP-1-Verbindungen …
Year 2007 in Dpmam
5 wordmarks: AuXxolog, Clair, DEZYME, DeniStop, Freelin, GROWTH VISION, INTERNATIONAL GROWTH MONITOR - NovoCare, InsuFlex, NORDIJECT, NovoSmart, NovoTwist, PenSet, STEEPASE, ULTRATARD …
14 Nov 2007
Annual report for the year ending 30/06/2007
14 Nov 2007
Annual report for the year ending 30/09/2007
19 Jun 2007
Capital: 647M DKK · Company statute
22 May 2007
Annual report for the year ending 31/03/2007
16 Mar 2007
Capital: 27M DKK
13 Mar 2007
Annual report for the year ending 31/12/2006
31 Dec 2006
Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006
Year 2006 in Epobase
89 European patent filings: Purification of Proteins Using Preparative Reverse Phase Chromatography (RPC) …
15 Dec 2006
Wordmark: “Victoza“
11 Dec 2006
Wordmark: “Levemir“
Year 2006 in Dpmap
27 patent filings: Polypeptidformulierungen Stabilisiert Mittels Ethylendiamin …
Year 2006 in Dpmam
10 trademark filings: COMBITARD, DRAXYMOX, EpiCare, LIPOSAM, MIXTARD, Midran, NOVO-LIN, RANDOZYME …
1 Nov 2006
Annual report for the year ending 30/09/2006
15 Aug 2006
Annual report for the year ending 30/06/2006
6 Jul 2006
Patent: Medication dispensing device with memory aid unit
23 Jun 2006
Capital: 673.9M DKK · Company statute
15 Jun 2006
Patent: Device for displaying data relevant to a diabetes patient
13 Jun 2006
Danish company filing
18 May 2006
Patent: Method and device for monitoring long-term and short-term effects of a treatment
9 May 2006
Annual report for the year ending 31/03/2006
3 Apr 2006
No longer Director (1)
31 Mar 2006
No longer Director (1)
21 Mar 2006
Board: Søren Th. Pedersen · No longer Board (1) · Auditor: Pricewaterhousecoopers Statsautoriseret A/S · No longer Auditor: PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab …
14 Mar 2006
Annual report for the year ending 31/12/2005
8 Mar 2006
No longer Chair of the board (1)
8 Mar 2006
Chair of the board (1)
8 Mar 2006
No longer Deputy member of the board (1)
8 Mar 2006
No longer Deputy member of the board (1)
8 Mar 2006
Deputy member of the board (1)
8 Mar 2006
Member of the board: Søren Th. Pedersen
8 Mar 2006
Deputy member of the board (1)
8 Mar 2006
Deputy member of the board (1)
8 Mar 2006
Deputy member of the board (1)
8 Mar 2006
No longer Auditor: PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab
8 Mar 2006
Auditor: Pricewaterhousecoopers Services Statsautoriseret A/S
31 Dec 2005
Balance sheet for 31/12/2005 · Earnings statement for 31/12/2005
Year 2005 in Dpmap
7 patent filings: Transparentes Elektronisches Markieren eines Medikamentenbehälters …
Year 2005 in Epobase
111 European patent filings: Medication Delivery Device with Bended Piston Rod …
Year 2005 in Dpmam
13 trademark filings: BioSure, DURALASE, DuetPen, ESTERZYME, ESTRIFAM, EcoDoc, INITARD, KAZUSASE, NOVOPEN, NovoFem, PENFILL, PHYTINEX, VAGIFEM
15 Nov 2005
Annual report for the year ending 30/09/2005
6 Oct 2005
Patent: Facility for displaying data relevant to a diabetic patient
27 Sept 2005
Annual report for the year ending 30/06/2005
16 Jun 2005
Wordmark: “Lets people get on with their lives“
11 May 2005
Annual report for the year ending 31/03/2005
6 May 2005
Patent: Medical Advice System
1 Apr 2005
No longer Auditor: Ernst & Young Statsautoriseret A/S
16 Mar 2005
Member of the board: Göran Ando · No longer Member of the board (1)
14 Mar 2005
Annual report for the year ending 31/12/2004
9 Mar 2005
Member of the board (1)
9 Mar 2005
No longer Member of the board (1)
9 Mar 2005
No longer Auditor: EY Danmark A/S
16 Mar 2004
Member of the board (1)
23 Jul 2002 via Novo Nordisk Pharma sp. z o.o. also 18/02/2002
Shareholding: Novo Nordisk Pharma sp. z o.o
22 Mar 2002
Director (1)
12 Mar 2002
Member of the board (1) · No longer Deputy member of the board (1)
12 Mar 2002
No longer Member of the board (1)
12 Mar 2002
No longer Deputy member of the board (1)
12 Mar 2002
Deputy member of the board (1)
12 Mar 2002
Deputy member of the board (1)
24 Apr 2001
No longer Auditor: Pricewaterhousecoopers Services Statsautoriseret A/S
2 Apr 2001
No longer Member of the board (1)
13 Nov 2000
No longer Director (1)
13 Nov 2000
Chair of the board (1)
13 Nov 2000
No longer Director (1)
13 Nov 2000
Persons
13 Nov 2000
Member of the board (1)
13 Nov 2000
Persons
13 Nov 2000
Director (1)
13 Nov 2000
No longer Member of the board (1)
13 Nov 2000
Director: Lars Rebien Sørensen
13 Nov 2000
No longer Director (1)
13 Nov 2000
Director (1)
13 Nov 2000
Director: Jesper Brandgaard
13 Nov 2000
Persons
13 Nov 2000
Member of the board: Anne Kverneland
13 Nov 2000
Director: Mads K. Thomsen
13 Nov 2000
Member of the board (1)
13 Nov 2000
Member of the board (1)
13 Nov 2000
Shareholder: Novo Holdings A/S · Voting rights: Novo Holdings A/S
30 Jun 2000
No longer Member of the board (1)
2 Apr 2000
No longer Member of the board (1)
23 Mar 2000
No longer Chair of the board (1)
1 Dec 1999
Wordmark: “GlucaGen“
25 Mar 1999
No longer Member of the board (1)
25 Mar 1999
No longer Deputy member of the board (1)
26 Mar 1998
Deputy member of the board (1)
26 Mar 1998
No longer Vice chair of the board (1)
26 Mar 1998
Deputy member of the board (1)
26 Mar 1998
No longer Member of the board (1)
26 Mar 1998
No longer Deputy member of the board (1)
26 Mar 1998
No longer Member of the board (1)
26 Mar 1998
No longer Deputy member of the board (1)
26 Mar 1998
No longer Deputy member of the board (1)
26 Mar 1998
Member of the board: Stig Strøbæk
26 Mar 1998
Deputy member of the board (1)
26 Mar 1998
No longer Deputy member of the board (1)
26 Mar 1998
Member of the board (1)
17 Dec 1997
No longer Director (1)
15 Nov 1995
No longer Director (1)
18 Nov 1994
No longer Director (1)
2 Jun 1994
No longer Deputy member of the board (1)
10 May 1994
No longer Deputy member of the board (1)
10 May 1994
No longer Member of the board (1)
10 May 1994
No longer Deputy member of the board (1)
10 May 1994
No longer Member of the board (1)
10 May 1994
No longer Deputy member of the board (1)
10 May 1994
No longer Member of the board (1)
10 May 1994
No longer Deputy member of the board (1)
6 Jan 1993
No longer Director (1)
26 Jun 1992
No longer Director (1)
9 Aug 1991
No longer Director (1)
3 May 1991
No longer Auditor: CJ Partnership I/S
4 Mar 1991
No longer Auditor: Pricewaterhousecoopers Services Statsautoriseret A/S
31 Aug 1990
No longer Director (1) · No longer Member of the board (1)
28 Jun 1990
No longer Member of the board (1)
8 May 1990
No longer Director (1)
8 May 1990
No longer Member of the board (1)
8 May 1990
No longer Director (1)
8 May 1990
No longer Deputy member of the board (1)
8 May 1990
No longer Deputy member of the board (1)
8 May 1990
No longer Deputy member of the board (1)
8 May 1990
No longer Member of the board (1)
8 May 1990
No longer Auditor: Pricewaterhousecoopers Services Statsautoriseret A/S
3 May 1989
No longer Member of the board (1)
3 May 1989
No longer Auditor (1)
3 May 1989
No longer Member of the board (1)
There are no publications matching your search.

Mentions

in Ler
No longer Direct parent: Velfærdsfonden FOR Novo Nordisk A/S, World Diabetes Foundation · Direct parent (7 companies)
in Ler
Ultimate parent (8 companies) · No longer Ultimate parent (3 companies)
25 Jun 2024 in Psc
Companies House - Persons with Significant Control
24 Jun 2024 in Psc
Companies House - Persons with Significant Control
29 Mar 2024 in Vr
Shareholding: Novo Nordisk s.r.o
8 Apr 2003 in Bmjfbv also 11/01/2002, 22/09/1994
Shareholding: Novo Nordisk Pharma GmbH
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.